Welcome to the 3rd Exosome Based Therapeutic Development Summit!

As the clinical development landscape grows and investment continues to pour into the industry, the field of exosome-based therapeutics is growing and maturing rapidly and excitingly.

The 3rd Exosome-Based Therapeutic Development Summit returns with a more comprehensive agenda than ever before, reuniting leading pharma, biotech, technology providers and academic teams to advance therapeutically relevant exosome-based therapeutics in regenerative medicine, autoimmunity, COVID-19 and beyond.

Deep diving into the key challenges such as sourcing, characterization, cargo loading, manufacturing and clinical development, this year’s summit will be your comprehensive roadmap to realizing, strategizing and advancing the full therapeutics and drug delivery opportunities offered by exosomes.

Tailor-made to showcase the latest innovations and interactively discuss the industry’s most important talking points, join leading biopharmaceutical Directors, VPs and C-Level Executives to successfully optimize, accelerate and scale your exosome-based therapeutics as next generation drugs for unmet clinical needs.

A Snapshot of Our Expert Speaker Faculty

David Haylock

CEO

VivaZome Therapeutics

Joe Nabhan

CSO

Vesigen

Mari Mitrani

CSO

Organicell Regenerative Medicine

Andreia Silva

Senior PostDoc Fellow

AstraZeneca

Jieun Lee

Scientist

AgeX Therapeutics

Joana Simoes Correia

CSO

Exogenus Therapeutics

Swetha Srinivasan

Senior Scientist

Abbvie

Proud To Partner With

LPB_Vertical_Black_RGB
Rbio_CorpID_Vert-01
ParticleMetrix_Logo 1080x1080